Experiencing a stroke while your body is already battling COVID-19 can be especially dangerous, this new study suggests. 

However, the two treatment options were associated with similar rates of long-term bleeding and ischemic events. 

The document, published in numerous journals, was designed to help trainees improve their understanding of cardiovascular computed tomography.

Nostrum Laboratories is at the center of this latest voluntary recall. 

No procedure-related deaths were reported, and an absolute LVEF improvement of more than 5% was present in nearly 49% of patients. 

The study's authors looked at nearly 3,000 clinical trials related to the ongoing pandemic. 

The new study focused on the early outcomes of more than 24,000 patients who participated in a total of nine different studies.

As cardiologists strive to recover from the tests and procedures lost during shutdown, healthcare teams are employing creative strategies to bring back apprehensive patients while safely and effectively managing readjusted workflows and protocols.

As AI inches into the workflows of residency program directors, many may need to prepare against delegating too much of the laborious candidate-selection task to an algorithm.